129 related articles for article (PubMed ID: 1586063)
1. Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody.
Hall SL; Sherman MP
Am Rev Respir Dis; 1992 May; 145(5):1172-7. PubMed ID: 1586063
[TBL] [Abstract][Full Text] [Related]
2. Role of pulmonary phagocytes in host defense against group B streptococci in preterm versus term rabbit lung.
Sherman MP; Johnson JT; Rothlein R; Hughes BJ; Smith CW; Anderson DC
J Infect Dis; 1992 Oct; 166(4):818-26. PubMed ID: 1527417
[TBL] [Abstract][Full Text] [Related]
3. Effect of different surfactants on pulmonary group B streptococcal infection in premature rabbits.
Sherman MP; Campbell LA; Merritt TA; Long WA; Gunkel JH; Curstedt T; Robertson B
J Pediatr; 1994 Dec; 125(6 Pt 1):939-47. PubMed ID: 7996369
[TBL] [Abstract][Full Text] [Related]
4. A new flow-cytometry-based opsonophagocytosis assay for the rapid measurement of functional antibody levels against Group B Streptococcus.
Fabbrini M; Sammicheli C; Margarit I; Maione D; Grandi G; Giuliani MM; Mori E; Nuti S
J Immunol Methods; 2012 Apr; 378(1-2):11-9. PubMed ID: 22309986
[TBL] [Abstract][Full Text] [Related]
5. Effects of pentoxifylline on in vivo leukocyte function and clearance of group B streptococci from preterm rabbit lungs.
Mah MP; Aeberhard EE; Gilliam MB; Sherman MP
Crit Care Med; 1993 May; 21(5):712-20. PubMed ID: 8482093
[TBL] [Abstract][Full Text] [Related]
6. Group B streptococcal lung infection in neonatal rabbits.
Sherman M; Goldstein E; Lippert W; Wennberg R
Pediatr Res; 1982 Mar; 16(3):209-12. PubMed ID: 7038607
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with surfactant and specific immunoglobulin reduces bacterial proliferation in experimental neonatal group B streptococcal pneumonia.
Herting E; Gan X; Rauprich P; Jarstrand C; Robertson B
Am J Respir Crit Care Med; 1999 Jun; 159(6):1862-7. PubMed ID: 10351931
[TBL] [Abstract][Full Text] [Related]
8. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
Butko P; Nicholson-Weller A; Wessels MR
J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
[TBL] [Abstract][Full Text] [Related]
9. The effect of type-specific polysaccharide capsule on the clearance of group B streptococci from the lungs of infant and adult rats.
Martin TR; Ruzinski JT; Rubens CE; Chi EY; Wilson CB
J Infect Dis; 1992 Feb; 165(2):306-14. PubMed ID: 1730897
[TBL] [Abstract][Full Text] [Related]
10. The role of complement and antibody in opsonophagocytosis of type II group B streptococci.
Baker CJ; Webb BJ; Kasper DL; Edwards MS
J Infect Dis; 1986 Jul; 154(1):47-54. PubMed ID: 3519791
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF-deficient mice are susceptible to pulmonary group B streptococcal infection.
LeVine AM; Reed JA; Kurak KE; Cianciolo E; Whitsett JA
J Clin Invest; 1999 Feb; 103(4):563-9. PubMed ID: 10021465
[TBL] [Abstract][Full Text] [Related]
13. Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.
Hastings MJ; Neil J; Easmon CS
Br J Exp Pathol; 1985 Jun; 66(3):317-23. PubMed ID: 3890914
[TBL] [Abstract][Full Text] [Related]
14. Variations in the opsonic requirements of group B streptococcus type III.
Hastings MJ; Easmon CS
Br J Exp Pathol; 1981 Oct; 62(5):519-25. PubMed ID: 7028075
[TBL] [Abstract][Full Text] [Related]
15. Surfactant protein-A binds group B streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice.
LeVine AM; Kurak KE; Wright JR; Watford WT; Bruno MD; Ross GF; Whitsett JA; Korfhagen TR
Am J Respir Cell Mol Biol; 1999 Feb; 20(2):279-86. PubMed ID: 9922219
[TBL] [Abstract][Full Text] [Related]
16. Antibody-independent and -dependent opsonization of group B Streptococcus requires the first component of complement C1.
Levy NJ; Kasper DL
Infect Immun; 1985 Jul; 49(1):19-24. PubMed ID: 3891622
[TBL] [Abstract][Full Text] [Related]
17. Lung function and bacterial proliferation in experimental neonatal pneumonia in ventilated rabbits exposed to monoclonal antibody to surfactant protein A.
Herting E; Strayer DS; Jarstrand C; Sun B; Robertson B
Lung; 1998; 176(2):123-31. PubMed ID: 9500297
[TBL] [Abstract][Full Text] [Related]
18. Type III group B Streptococcus: functional interaction with IgG subclass antibodies.
Givner LB; Baker CJ; Edwards MS
J Infect Dis; 1987 Mar; 155(3):532-9. PubMed ID: 3543156
[TBL] [Abstract][Full Text] [Related]
19. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
[TBL] [Abstract][Full Text] [Related]
20. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
Shigeoka AO; Jensen CL; Pincus SH; Hill HR
J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
